Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.
Saved in:
| Title: | Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study. |
|---|---|
| Authors: | Weisman MH (AUTHOR), Moreland LW (AUTHOR), Furst DE (AUTHOR), Weinblatt ME (AUTHOR), Keystone EC (AUTHOR), Paulus HE (AUTHOR), Teoh LS (AUTHOR), Velagapudi RB (AUTHOR), Noertersheuser PA (AUTHOR), Granneman GR (AUTHOR), Fischkoff SA (AUTHOR), Chartash EK (AUTHOR) |
| Source: | Clinical Therapeutics. Jun2003, Vol. 25 Issue 6, p1700-1721. 22p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 106692920 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Weisman+MH%22">Weisman MH</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Moreland+LW%22">Moreland LW</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Furst+DE%22">Furst DE</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Weinblatt+ME%22">Weinblatt ME</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Keystone+EC%22">Keystone EC</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Paulus+HE%22">Paulus HE</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Teoh+LS%22">Teoh LS</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Velagapudi+RB%22">Velagapudi RB</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Noertersheuser+PA%22">Noertersheuser PA</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Granneman+GR%22">Granneman GR</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fischkoff+SA%22">Fischkoff SA</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chartash+EK%22">Chartash EK</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Clinical+Therapeutics%22">Clinical Therapeutics</searchLink>. Jun2003, Vol. 25 Issue 6, p1700-1721. 22p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=106692920 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/s0149-2918(03)80164-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 22 StartPage: 1700 Titles: – TitleFull: Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Weisman MH – PersonEntity: Name: NameFull: Moreland LW – PersonEntity: Name: NameFull: Furst DE – PersonEntity: Name: NameFull: Weinblatt ME – PersonEntity: Name: NameFull: Keystone EC – PersonEntity: Name: NameFull: Paulus HE – PersonEntity: Name: NameFull: Teoh LS – PersonEntity: Name: NameFull: Velagapudi RB – PersonEntity: Name: NameFull: Noertersheuser PA – PersonEntity: Name: NameFull: Granneman GR – PersonEntity: Name: NameFull: Fischkoff SA – PersonEntity: Name: NameFull: Chartash EK IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: Jun2003 Type: published Y: 2003 Identifiers: – Type: issn-print Value: 01492918 Numbering: – Type: volume Value: 25 – Type: issue Value: 6 Titles: – TitleFull: Clinical Therapeutics Type: main |
| ResultId | 1 |